A Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics

Status: open

A phase 1B/2 multi-center, double-blind (principal investigators and study subjects blinded, sponsor unblinded), placebo-controlled, randomized, single-ascending dose study to assess the safety, pharmacokinetics, and pharmacodynamics of DS-1040B in subject with AIS.

Treatment for Acute Ischemic Stroke

Contact Us Or call 251-665-8375

Description

This is a Phase 1b/2, double-blind (principal investigator and study subjects blinded, Sponsor unblinded), placebo controlled, randomized, single-ascending dose, multi-center study to assess the safety, tolerability, PK, and pharmacodynamics (PD) of DS-1040b in subjects with AIS.

Sponsors

This trial is sponsored by Daiichi Sankyo.

Providers Associated With This Trial

Principle Investigator

Sub Investigators

This link will open in a new tab or window.